Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Transplantation | 32 | 2023 | 3112 | 5.060 |
Why?
|
Graft Rejection | 13 | 2023 | 4397 | 1.430 |
Why?
|
Heart Defects, Congenital | 9 | 2022 | 4583 | 0.920 |
Why?
|
Heart Failure | 13 | 2023 | 10895 | 0.890 |
Why?
|
Heart Diseases | 4 | 2023 | 2789 | 0.860 |
Why?
|
Chickenpox | 1 | 2022 | 131 | 0.800 |
Why?
|
Immunosuppressive Agents | 7 | 2023 | 4153 | 0.790 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2016 | 3511 | 0.710 |
Why?
|
Blood Group Incompatibility | 1 | 2020 | 146 | 0.680 |
Why?
|
Cardiomyopathies | 3 | 2022 | 1912 | 0.580 |
Why?
|
Tissue and Organ Procurement | 2 | 2022 | 896 | 0.540 |
Why?
|
Child | 39 | 2023 | 77709 | 0.530 |
Why?
|
Coronary Disease | 2 | 2023 | 6077 | 0.530 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2020 | 851 | 0.490 |
Why?
|
Kidney Transplantation | 4 | 2023 | 4251 | 0.480 |
Why?
|
Hypoplastic Left Heart Syndrome | 2 | 2018 | 573 | 0.480 |
Why?
|
Heart-Assist Devices | 5 | 2023 | 1195 | 0.470 |
Why?
|
Policy | 3 | 2023 | 508 | 0.460 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2013 | 329 | 0.450 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2013 | 126 | 0.430 |
Why?
|
Waiting Lists | 5 | 2023 | 692 | 0.410 |
Why?
|
Hospitals, Pediatric | 3 | 2017 | 1775 | 0.410 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2013 | 282 | 0.380 |
Why?
|
Tissue Donors | 2 | 2022 | 2241 | 0.370 |
Why?
|
Transplantation | 1 | 2011 | 217 | 0.360 |
Why?
|
Perioperative Care | 1 | 2017 | 1002 | 0.350 |
Why?
|
ABO Blood-Group System | 2 | 2023 | 367 | 0.350 |
Why?
|
Graft Survival | 6 | 2023 | 3737 | 0.330 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2200 | 0.330 |
Why?
|
Fontan Procedure | 3 | 2021 | 776 | 0.320 |
Why?
|
Myocarditis | 3 | 2021 | 771 | 0.320 |
Why?
|
Postoperative Complications | 5 | 2020 | 15297 | 0.310 |
Why?
|
Vascular Diseases | 2 | 2015 | 1161 | 0.310 |
Why?
|
Child, Preschool | 17 | 2021 | 41005 | 0.300 |
Why?
|
Echocardiography, Doppler | 1 | 2011 | 935 | 0.290 |
Why?
|
Antibodies | 2 | 2023 | 2460 | 0.290 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2015 | 2016 | 0.280 |
Why?
|
Organ Transplantation | 3 | 2023 | 1140 | 0.280 |
Why?
|
Models, Statistical | 1 | 2021 | 5101 | 0.270 |
Why?
|
Thrombocytosis | 1 | 2005 | 81 | 0.260 |
Why?
|
Radiopharmaceuticals | 1 | 2015 | 2645 | 0.260 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2005 | 197 | 0.260 |
Why?
|
Tacrolimus | 3 | 2023 | 743 | 0.260 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2005 | 299 | 0.250 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2005 | 351 | 0.250 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2005 | 437 | 0.240 |
Why?
|
Myocardium | 3 | 2020 | 4772 | 0.240 |
Why?
|
Coronary Angiography | 4 | 2022 | 4576 | 0.230 |
Why?
|
Heart | 2 | 2021 | 4464 | 0.230 |
Why?
|
Death, Sudden, Cardiac | 1 | 2011 | 1541 | 0.220 |
Why?
|
Humans | 53 | 2023 | 744366 | 0.220 |
Why?
|
Heart-Lung Transplantation | 1 | 2022 | 71 | 0.210 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3154 | 0.200 |
Why?
|
Heart Aneurysm | 1 | 2021 | 120 | 0.200 |
Why?
|
Lighting | 1 | 2023 | 231 | 0.200 |
Why?
|
Protein-Losing Enteropathies | 1 | 2021 | 44 | 0.190 |
Why?
|
Herpesvirus 3, Human | 1 | 2022 | 204 | 0.190 |
Why?
|
Mycophenolic Acid | 1 | 2023 | 343 | 0.190 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2005 | 689 | 0.190 |
Why?
|
Translocation, Genetic | 1 | 2005 | 1420 | 0.180 |
Why?
|
Complement Inactivating Agents | 1 | 2019 | 50 | 0.180 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5445 | 0.170 |
Why?
|
Positron-Emission Tomography | 1 | 2015 | 6234 | 0.170 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2021 | 223 | 0.170 |
Why?
|
Bronchitis | 1 | 2019 | 200 | 0.170 |
Why?
|
Immune System Diseases | 1 | 2021 | 261 | 0.170 |
Why?
|
Coronary Artery Disease | 4 | 2022 | 6486 | 0.160 |
Why?
|
Adolescent | 14 | 2023 | 85779 | 0.160 |
Why?
|
Stroke Volume | 1 | 2011 | 5006 | 0.150 |
Why?
|
Phytotherapy | 1 | 2020 | 298 | 0.150 |
Why?
|
Heart Atria | 1 | 2023 | 1356 | 0.150 |
Why?
|
Biopsy | 4 | 2021 | 6755 | 0.140 |
Why?
|
Barth Syndrome | 1 | 2017 | 25 | 0.140 |
Why?
|
Carboxylic Acids | 1 | 2017 | 97 | 0.140 |
Why?
|
American Heart Association | 1 | 2021 | 1057 | 0.140 |
Why?
|
Aorta, Abdominal | 1 | 2019 | 646 | 0.140 |
Why?
|
Patient Selection | 2 | 2021 | 4216 | 0.140 |
Why?
|
Clostridium Infections | 1 | 2023 | 548 | 0.140 |
Why?
|
Norwood Procedures | 1 | 2018 | 182 | 0.140 |
Why?
|
Male | 27 | 2023 | 350115 | 0.130 |
Why?
|
Retrospective Studies | 14 | 2023 | 77460 | 0.130 |
Why?
|
Primary Graft Dysfunction | 1 | 2016 | 93 | 0.130 |
Why?
|
Endocardium | 1 | 2016 | 263 | 0.130 |
Why?
|
Acyltransferases | 1 | 2017 | 294 | 0.130 |
Why?
|
Marijuana Smoking | 1 | 2018 | 253 | 0.130 |
Why?
|
Attitude of Health Personnel | 2 | 2020 | 3841 | 0.120 |
Why?
|
Ammonia | 1 | 2015 | 239 | 0.120 |
Why?
|
Lung Transplantation | 1 | 2022 | 1155 | 0.120 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15078 | 0.120 |
Why?
|
Iloprost | 1 | 2013 | 29 | 0.110 |
Why?
|
Brazil | 1 | 2017 | 1270 | 0.110 |
Why?
|
Drug Therapy, Combination | 1 | 2023 | 6489 | 0.110 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2015 | 262 | 0.110 |
Why?
|
Central Nervous System Stimulants | 1 | 2021 | 1148 | 0.110 |
Why?
|
Risk Factors | 8 | 2021 | 72296 | 0.100 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 638 | 0.100 |
Why?
|
Consensus | 1 | 2021 | 2960 | 0.100 |
Why?
|
Canada | 1 | 2017 | 2065 | 0.100 |
Why?
|
Infant | 9 | 2022 | 35134 | 0.100 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4185 | 0.100 |
Why?
|
Giant Cells | 2 | 2021 | 187 | 0.100 |
Why?
|
Microvessels | 1 | 2015 | 544 | 0.090 |
Why?
|
Program Development | 1 | 2017 | 1316 | 0.090 |
Why?
|
Young Adult | 10 | 2023 | 56429 | 0.090 |
Why?
|
Veins | 1 | 2015 | 770 | 0.090 |
Why?
|
Female | 20 | 2023 | 380193 | 0.090 |
Why?
|
Genetic Variation | 1 | 2005 | 6542 | 0.090 |
Why?
|
Pediatrics | 2 | 2015 | 3475 | 0.090 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2015 | 554 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3279 | 0.090 |
Why?
|
Health Care Surveys | 1 | 2017 | 2453 | 0.090 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2019 | 1186 | 0.090 |
Why?
|
Time Factors | 6 | 2020 | 40075 | 0.090 |
Why?
|
Heart Ventricles | 1 | 2021 | 3817 | 0.090 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2013 | 652 | 0.080 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2020 | 2073 | 0.080 |
Why?
|
ROC Curve | 1 | 2016 | 3528 | 0.080 |
Why?
|
Vasodilator Agents | 1 | 2013 | 976 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 2110 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1620 | 0.080 |
Why?
|
Transplantation, Homologous | 2 | 2020 | 4777 | 0.080 |
Why?
|
HLA Antigens | 1 | 2013 | 1382 | 0.080 |
Why?
|
United States | 6 | 2022 | 69872 | 0.080 |
Why?
|
Adipose Tissue | 1 | 2019 | 3280 | 0.070 |
Why?
|
Genetic Testing | 1 | 2020 | 3444 | 0.070 |
Why?
|
Cholesterol | 1 | 2016 | 2919 | 0.070 |
Why?
|
Developmental Disabilities | 1 | 2015 | 1456 | 0.070 |
Why?
|
Bone Marrow | 1 | 2017 | 2948 | 0.070 |
Why?
|
Metaphase | 1 | 2005 | 151 | 0.070 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 3658 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12356 | 0.060 |
Why?
|
Mutation | 2 | 2020 | 29786 | 0.060 |
Why?
|
Karyotyping | 1 | 2005 | 1243 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 4639 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3611 | 0.060 |
Why?
|
Treatment Outcome | 6 | 2023 | 63107 | 0.050 |
Why?
|
Cytidine Monophosphate | 1 | 2022 | 19 | 0.050 |
Why?
|
Adult | 8 | 2023 | 214052 | 0.050 |
Why?
|
Endothelial Cells | 1 | 2015 | 3486 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2023 | 39052 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10183 | 0.050 |
Why?
|
Echocardiography, Stress | 1 | 2022 | 131 | 0.050 |
Why?
|
Milrinone | 1 | 2021 | 84 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2015 | 2758 | 0.050 |
Why?
|
Anthracyclines | 1 | 2023 | 288 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6539 | 0.050 |
Why?
|
Prognosis | 4 | 2022 | 29060 | 0.050 |
Why?
|
Age Factors | 2 | 2021 | 18373 | 0.050 |
Why?
|
Inflammation | 1 | 2019 | 10637 | 0.040 |
Why?
|
Kidney | 1 | 2015 | 7184 | 0.040 |
Why?
|
Cardiotonic Agents | 1 | 2021 | 535 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 930 | 0.040 |
Why?
|
Prospective Studies | 4 | 2018 | 53290 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 21833 | 0.040 |
Why?
|
Organizational Policy | 1 | 2020 | 429 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11718 | 0.040 |
Why?
|
Transcription Factors | 1 | 2017 | 12207 | 0.040 |
Why?
|
Exercise | 1 | 2013 | 5615 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18034 | 0.040 |
Why?
|
Respiration Disorders | 1 | 2019 | 371 | 0.030 |
Why?
|
Employment | 1 | 2023 | 1132 | 0.030 |
Why?
|
Registries | 1 | 2011 | 8091 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2618 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2020 | 25628 | 0.030 |
Why?
|
Survival Rate | 2 | 2021 | 12788 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1880 | 0.030 |
Why?
|
Intelligence Tests | 1 | 2015 | 505 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2019 | 862 | 0.030 |
Why?
|
Phlebography | 1 | 2015 | 333 | 0.030 |
Why?
|
Endothelin-1 | 1 | 2015 | 314 | 0.030 |
Why?
|
Social Class | 1 | 2023 | 1997 | 0.030 |
Why?
|
Sample Size | 1 | 2017 | 845 | 0.030 |
Why?
|
Cohort Studies | 2 | 2017 | 40559 | 0.030 |
Why?
|
Incidence | 1 | 2011 | 20952 | 0.030 |
Why?
|
Survivors | 1 | 2023 | 2291 | 0.030 |
Why?
|
Middle Aged | 6 | 2020 | 213390 | 0.030 |
Why?
|
Vascular Patency | 1 | 2015 | 887 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2015 | 1107 | 0.020 |
Why?
|
Leukocytes | 1 | 2019 | 2045 | 0.020 |
Why?
|
Hemodynamics | 1 | 2021 | 4196 | 0.020 |
Why?
|
Aspirin | 1 | 2023 | 3283 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2015 | 764 | 0.020 |
Why?
|
Angioplasty, Balloon | 1 | 2015 | 653 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 19905 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2013 | 1105 | 0.020 |
Why?
|
Chronic Disease | 2 | 2015 | 9145 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 2017 | 1049 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7785 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2019 | 5974 | 0.020 |
Why?
|
Program Evaluation | 1 | 2017 | 2488 | 0.020 |
Why?
|
Electrocardiography | 1 | 2021 | 6442 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2020 | 3107 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2016 | 1486 | 0.020 |
Why?
|
Aged | 4 | 2020 | 163288 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4751 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4600 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5181 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2029 | 0.020 |
Why?
|
Radiography, Interventional | 1 | 2015 | 1095 | 0.020 |
Why?
|
Models, Biological | 1 | 2023 | 9584 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3582 | 0.020 |
Why?
|
Animals | 2 | 2015 | 168768 | 0.020 |
Why?
|
Patient Care Team | 1 | 2017 | 2531 | 0.020 |
Why?
|
Exercise Test | 1 | 2013 | 2073 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2015 | 5077 | 0.020 |
Why?
|
Macrophages | 1 | 2019 | 5660 | 0.020 |
Why?
|
Boston | 1 | 2017 | 9312 | 0.010 |
Why?
|
Stents | 1 | 2015 | 3282 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16367 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15535 | 0.010 |
Why?
|
Asthma | 1 | 2019 | 6010 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 9955 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 13035 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13286 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7914 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9445 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2013 | 12025 | 0.010 |
Why?
|
MicroRNAs | 1 | 2015 | 3751 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17446 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2015 | 4468 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 21748 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 12073 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 35425 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20130 | 0.010 |
Why?
|